These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9402381)

  • 1. Quinolone arthropathy in animals versus children.
    Burkhardt JE; Walterspiel JN; Schaad UB
    Clin Infect Dis; 1997 Nov; 25(5):1196-204. PubMed ID: 9402381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
    Sendzik J; Lode H; Stahlmann R
    Int J Antimicrob Agents; 2009 Mar; 33(3):194-200. PubMed ID: 18835137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolone arthropathy--acute toxicity to immature articular cartilage.
    Gough AW; Kasali OB; Sigler RE; Baragi V
    Toxicol Pathol; 1992; 20(3 Pt 1):436-49; discussion 449-50. PubMed ID: 1295072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on articular and general toxicity of orally administered ozenoxacin in juvenile rats and dogs.
    González Borroto JI; Awori MS; Chouinard L; Smith SY; Tarragó C; Blazquez T; Gargallo-Viola D; Zsolt I
    Future Microbiol; 2018 May; 13():31-40. PubMed ID: 29745239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey.
    Danisovicová A; Brezina M; Belan S; Kayserová H; Kaiserová E; Hruskovic I; Orosová K; Dluholucký S; Galova K; Mathéova E
    Chemotherapy; 1994; 40(3):209-14. PubMed ID: 8205939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin.
    Linseman DA; Hampton LA; Branstetter DG
    Fundam Appl Toxicol; 1995 Nov; 28(1):59-64. PubMed ID: 8566484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolones in children. Are concerns over arthropathy justified?
    Stahlmann R; Förster C; Van Sickle D
    Drug Saf; 1993 Dec; 9(6):397-403. PubMed ID: 8129861
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenesis of quinolone-induced arthropathy: a review of hypotheses.
    Maślanka T; Jaroszewski JJ; Chrostowska M
    Pol J Vet Sci; 2004; 7(4):323-31. PubMed ID: 15633793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic quinolone antibiotics in children: a review of the use and safety.
    Grady RW
    Expert Opin Drug Saf; 2005 Jul; 4(4):623-30. PubMed ID: 16011441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cartilage-damaging effect of quinolones].
    Stahlmann R
    Infection; 1991; 19 Suppl 1():S38-46. PubMed ID: 2007514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-floxacin induced arthropathy.
    Biswal N; Mathai B; Bhatia BD
    Indian Pediatr; 1993 May; 30(5):718-9. PubMed ID: 8282410
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoroquinolone toxicities. An update.
    Lietman PS
    Drugs; 1995; 49 Suppl 2():159-63. PubMed ID: 8549287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Children as a special population at risk--quinolones as an example for xenobiotics exhibiting skeletal toxicity.
    Stahlmann R
    Arch Toxicol; 2003 Jan; 77(1):7-11. PubMed ID: 12491034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential quinolone-induced cartilage toxicity in children.
    Camp KA; Miyagi SL; Schroeder DJ
    Ann Pharmacother; 1994 Mar; 28(3):336-8. PubMed ID: 8193422
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of quinolones in pediatric patients.
    Adam D
    Rev Infect Dis; 1989; 11 Suppl 5():S1113-6. PubMed ID: 2672245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolone-induced arthropathy in immature Equidae.
    Specht TE; Frederick G
    J Am Vet Med Assoc; 1991 Feb; 198(4):516. PubMed ID: 2019522
    [No Abstract]   [Full Text] [Related]  

  • 17. [On fluoroquinolones treatment safety in children (clinical, morphological and catamnesis data)].
    Postnikov SS; Semykin SIu; Nazhimov VP; Novichkova GA
    Antibiot Khimioter; 2002; 47(9):14-7. PubMed ID: 12619515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of quinolones in the treatment of Pseudomonas aeruginosa infections in children with cystic fibrosis].
    Milio MC; Campana S
    Pediatr Med Chir; 1995; 17(1):53-5. PubMed ID: 7739928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical risk/benefit analysis of pefloxacine use in children under 15 years--the problem of arthralgias.
    Chevais M; Reinert P; Rondeau MC; Tobelem R; Albengres E; Riant P; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):306-9. PubMed ID: 3476471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.